Healthcare Triangle, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $13.9M | $11.7M | $33.2M | $45.9M | $35.3M |
| Cost of revenue | $12.0M | $8.8M | $26.4M | $34.6M | $24.7M |
| Gross profit | $1.2B | $1.1B | $1.1B | — | — |
| Selling, general & administrative | — | — | — | $0 | $0 |
| Research and development | $536,000 | $429,000 | $799,000 | $8.1M | $5.3M |
| Operating expenses | $11.7M | $7.6M | $14.5M | $27.6M | $15.9M |
| Operating income | -$9.8M | -$4.8M | -$7.7M | -$16.3M | -$5.4M |
| Interest expense | $567,000 | — | — | $212,000 | $567,000 |
| Pretax income | -$9.5M | -$6.0M | -$8.7M | -$9.5M | -$5.9M |
| Income tax expense | — | $12,000 | $35,000 | $506,000 | $24,000 |
| Net income | -$9.5M | -$6.0M | -$8.7M | -$14.4M | -$5.9M |
| Balance Sheet | |||||
| Cash and equivalents | $7.6M | $20,000 | $1.2M | $1.3M | $1.8M |
| Current assets | $13.2M | $1.5M | $5.7M | $8.0M | $11.8M |
| Total assets | $22.7M | $2.0M | $6.9M | $13.3M | $24.6M |
| Current liabilities | $12.8M | $7.1M | $8.2M | $6.6M | $6.3M |
| Total liabilities | — | $7.1M | $8.2M | $7.2M | $8.5M |
| Total debt | $10.5M | — | — | — | — |
| Stockholders' equity | $9.9M | -$5.1M | -$1.4M | $6.0M | $14.2M |
| Cash Flow Statement | |||||
| Cash from operations | -$16.5M | -$1.1M | -$2.2M | -$5.4M | -$7.1M |
| Depreciation and amortization | $705,000 | $889,000 | $1.6M | $2.9M | $1.4M |
| Stock-based compensation | $451,000 | $87,000 | $166,000 | $257,000 | $52,000 |
| Capital expenditure | $6,000 | — | $12,000 | $40,000 | — |
| Free cash flow | -$16.5M | — | -$2.2M | -$5.4M | — |
| Share repurchases | — | — | — | $141,000 | — |
| Impairments | — | $0 | $1.7M | $4.4M | — |
Shares outstanding 2.0M · Free float 68.7%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.